Back to Journals » Drug Design, Development and Therapy » Volume 14

Clinical Trial Report

First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers

       
Total article views   HTML views PDF downloads Totals
6,169 Dovepress* 5,644+ 794 6,438
PubMed Central* 525 157 682
Totals 6,169 951 7,120
*Since 5 August 2020

View citations on PubMed Central and Google Scholar